Symbol="CNSP"
AssetType="Common Stock"
Name="Cns Pharmaceuticals Inc"
Description="CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas."
CIK="1729427"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="7983700"
EBITDA="-17497994"
PERatio="None"
PEGRatio="None"
BookValue="0.593"
DividendPerShare="0"
DividendYield="0"
EPS="-9.43"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.158"
ReturnOnEquityTTM="-2.505"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-9.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="10"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.401"
EVToRevenue="-"
EVToEBITDA="0.289"
Beta="1.218"
num_52WeekHigh="8.64"
num_52WeekLow="0.611"
num_50DayMovingAverage="2.091"
num_200DayMovingAverage="2.244"
SharesOutstanding="4201900"
DividendDate="None"
ExDividendDate="None"
symbol="CNSP"
open="1.75"
high="1.98"
low="1.71"
price="1.90"
volume="116940.00"
latest_trading_day="2023-08-25"
previous_close="1.75"
change="0.15"
change_percent="8.5714%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="16"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="84"
Volume_recent_avg="2358742"
Change_recent_avg="0.01"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-0.62"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="84"
Aroon_momentum_negative="16"
image_negative_thumbnail_id_1="1121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0154.jpeg"
image_negative_thumbnail_id_2="1125"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0158.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="1012"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0174.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
